Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.
01 1Seqens
02 1Moehs Iberica
03 1Cohance Lifesciences
04 1ASolution Pharmaceuticals
05 1Harman Finochem
06 1PAION UK LTD
07 1Teva Pharmaceutical Industries
01 1France
02 3India
03 1Israel
04 1Spain
05 1United Kingdom
01 3Active
02 4Blank
01 7Blank
01 7Blank
01 7Blank
Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.
NDC Package Code : 58175-0648
Start Marketing Date : 2022-08-31
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Moehs Group, a reference company in the production of pharmaceutical active ingredients.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 36332
Submission : 2021-10-07
Status : Active
Type : II
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
ASolution Pharmaceuticals: Your Partner for cGMP Development & Manufacturing Services – Supplying APIs, FDFs, and Specialty Molecules.
GDUFA
DMF Review : Reviewed
Rev. Date : 2024-08-29
Pay. Date : 2024-05-01
DMF Number : 39813
Submission : 2024-05-30
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 32748
Submission : 2019-03-15
Status : Active
Type : II
We have 7 companies offering Remimazolam Besylate
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
